Patent directory · USPTO A61K / A61P
Patents matching “interleukin-”
120 pharma patents match "interleukin-" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 120 pharmaceutical patents matching "interleukin-" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12359204
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 12291571
Methods for reducing eosinophilic infiltration by administering an anti-interleukin-4 receptor (IL4R) antibody
granted -
US 12280108
Vaccines having an antigen and interleukin-21 as an adjuvant
granted -
US 12247206
Soluble interleukin-7 receptor (SIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 12201673
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 12157762
Tethered interleukin-15 and interleukin-21
granted -
US 12077593
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
granted -
US 12036283
Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods
granted -
US 12018057
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 11981739
Chimeric antigen receptor specific for interleukin-23 receptor
granted -
US 11981716
Activatable interleukin-2 polypeptides and methods of use thereof
granted -
US 11944666
Treatment of inflammatory conditions delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11939361
Compositions of peptide inhibitors of Interleukin-23 receptor
granted -
US 11926670
Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies
granted -
US 11897874
Compounds and methods for modulating Interleukin-2-inducible T-cell kinase
granted -
US 11884748
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
granted -
US 11866503
Methods for treating inflammatory conditions of the airway or lungs by administering antagonist monoclonal antibodies to interleukin-33 and interleukin-4 receptor
granted -
US 11844765
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 11845808
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
granted -
US 11807853
Soluble interleukin-7 receptor (sIL7R) modulating therapy to treat autoimmune diseases and cancer
granted -
US 11718655
Masked interleukin-12 polypeptides
granted -
US 11701384
Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments
granted -
US 11680090
Interleukin-2 fusion proteins and uses thereof
granted -
US 11535658
Activatable interleukin-2 polypeptides and methods of use thereof
granted